Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic

Схожие документы

• Expression and Immunogenicity of Human Immunodeficiency Virus Type 1 Gag Expressed by a Replication-Competent Rhabdovirus-Based Vaccine Vector
  по: McGettigan, James P., et al.
  Опубликовано: (2001)
• Covalently Linked Human Immunodeficiency Virus Type 1 gp120/gp41 Is Stably Anchored in Rhabdovirus Particles and Exposes Critical Neutralizing Epitopes
  по: McKenna, Philip M., et al.
  Опубликовано: (2003)
• Immunogenicity Study of Glycoprotein-Deficient Rabies Virus Expressing Simian/Human Immunodeficiency Virus SHIV(89.6P) Envelope in a Rhesus Macaque
  по: McKenna, Philip M., et al.
  Опубликовано: (2004)
• Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector Genome
  по: McGettigan, James P., et al.
  Опубликовано: (2003)
• A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection
  по: Foley, Heather D., et al.
  Опубликовано: (2000)